Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Treace Medical Concepts, Inc. - Common Stock (NQ: TMCI )

7.940 -0.240 (-2.93%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Treace Medical Concepts, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Treace Announces Participation in the UBS Global Healthcare Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Earnings Preview For Treace Medical Concepts
Via Benzinga
Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure
Positions Treace to Significantly Increase Penetration into Overall Bunion Market and Expand Surgeon Customer Base 
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Beyond The Numbers: 8 Analysts Discuss Treace Medical Concepts Stock
Via Benzinga
Treace Comments on CMS’ 2025 Final Rule for Hospital Outpatient and ASC Settings
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
Unveiling 6 Analyst Insights On Treace Medical Concepts
Via Benzinga
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Treace to Report Third Quarter 2024 Financial Results on November 5, 2024
From Treace Medical Concepts, Inc.
Via GlobeNewswire
TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
H&R Block Posts Upbeat Earnings, Joins Alibaba Group, CI&T And Other Big Stocks Moving Higher On Friday
Via Benzinga
Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Reports Second Quarter 2024 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Highlights New Product Innovations and Updated Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2024
From Treace Medical Concepts, Inc.
Via GlobeNewswire
3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
Insiders are buying the dips in these three stocks, which suggests a rebound is coming. There are reasons the market dipped, but the sell-offs are overdone. 
Via MarketBeat
Topics Initial Public Offering
Exposures Securities Market
Treace to Report Second Quarter 2024 Financial Results on August 6, 2024
From Treace Medical Concepts, Inc.
Via GlobeNewswire
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
Via Benzinga
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Treace Medical Concepts, Inc. (TMCI)
From Kirby McInerney LLP
Via Business Wire
Orthopedic Devices Maker Treace Medical Concepts' Gloomy Forecast Cast Concerns Over Long-Term Viability
Treace Medical Concepts reports Q1 EPS loss of $(0.30), sales hit $51.11 million, up 21%. Surge in procedure kits sold due to expanded surgeon base and product mix shift. FY24 sales guidance adjusted... 
Via Benzinga
Dow Gains 150 Points; Emerson Electric Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Crude Oil Moves Higher; Inspire Medical Systems Shares Plummet
Via Benzinga
Exposures Fossil Fuels
Nasdaq Down Over 50 Points; Uber Posts Q1 Loss
Via Benzinga
Why Is DoubleVerify (DV) Stock Down 39% Today?
DoubleVerify stock is falling on Wednesday as DV shareholders are disappointed by the company's weak guidance in its Q1 earnings report. 
Via InvestorPlace
Why Is Treace Medical Concepts (TMCI) Stock Down 59% Today?
Treace Medical Concepts stock is falling on Wednesday as investors in TMCI shares react to a poor guidance in its latest earnings report. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.